Source: EURLEX
Language: en
Format: md

|  |  |  |  |
| --- | --- | --- | --- |
| 29.8.2022 | EN | Official Journal of the European Union | C 326/25 |

---

Action brought on 6 July 2022 — Laboratorios Ern v EUIPO — Arrowhead Pharmaceuticals (TRiM)

(Case T-428/22)

(2022/C 326/34)

Language in which the application was lodged: English

Parties

Applicant: Laboratorios Ern, SA (Barcelona, Spain) (represented by: S. Correa Rodríguez, lawyer)

Defendant: European Union Intellectual Property Office (EUIPO)

Other party to the proceedings before the Board of Appeal: Arrowhead Pharmaceuticals, Inc. (Pasadena, California, United States)

Details of the proceedings before EUIPO

Proprietor of the trade mark at issue: Other party to the proceedings before the Board of Appeal

Trade mark at issue: International registration designating the European Union in respect of the word mark TRiM — International registration designating the European Union No 1 411 062

Procedure before EUIPO: Opposition proceedings

Contested decision: Decision of the Second Board of Appeal of EUIPO of 12 April 2022 in Case R 1158/2021-2

Form of order sought

The applicant claims that the Court should:

|  |  |
| --- | --- |
| — | revoke the contested decision and reject the European designation of the international trademark No 1 411 062 TRIM for all goods and services; |

|  |  |
| --- | --- |
| — | impose the costs to the defendant and, in case Arrowhead Pharmaceuticals, Inc. decides to intervene in the present proceedings, to Arrowhead Pharmaceuticals, Inc. |

Plea in law

|  |  |
| --- | --- |
| — | Infringement of Article 8(1)(b) of Regulation (EU) 2017/1001 of the European Parliament and of the Council. |

---

[Top](#document1)